Moreover, some previous studies have shown long-term stability of tau in AD, despite changes in the patient’s cognitive and global performance [14, 17], while other studies described that tau levels are increased at follow-up [18, 19]. The gene discussed is MAPT; the disease is Alzheimer disease.